DE60011686D1 - Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis - Google Patents

Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis

Info

Publication number
DE60011686D1
DE60011686D1 DE60011686T DE60011686T DE60011686D1 DE 60011686 D1 DE60011686 D1 DE 60011686D1 DE 60011686 T DE60011686 T DE 60011686T DE 60011686 T DE60011686 T DE 60011686T DE 60011686 D1 DE60011686 D1 DE 60011686D1
Authority
DE
Germany
Prior art keywords
dermatosis
betamethasone
dermatitis
psoriasis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60011686T
Other languages
English (en)
Other versions
DE60011686T2 (de
Inventor
Elisabetta Donati
Irina Rapaport
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altergon SA
Original Assignee
Altergon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon SA filed Critical Altergon SA
Publication of DE60011686D1 publication Critical patent/DE60011686D1/de
Application granted granted Critical
Publication of DE60011686T2 publication Critical patent/DE60011686T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60011686T 1999-03-05 2000-02-04 Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis Expired - Lifetime DE60011686T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI990449 1999-03-05
IT1999MI000449A IT1309588B1 (it) 1999-03-05 1999-03-05 Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.

Publications (2)

Publication Number Publication Date
DE60011686D1 true DE60011686D1 (de) 2004-07-29
DE60011686T2 DE60011686T2 (de) 2005-06-30

Family

ID=11382159

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60011686T Expired - Lifetime DE60011686T2 (de) 1999-03-05 2000-02-04 Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis

Country Status (12)

Country Link
US (1) US6379695B1 (de)
EP (1) EP1034780B1 (de)
AT (1) ATE269697T1 (de)
CA (1) CA2288482C (de)
CZ (1) CZ295714B6 (de)
DE (1) DE60011686T2 (de)
DK (1) DK1034780T3 (de)
ES (1) ES2222860T3 (de)
HU (1) HU225599B1 (de)
IT (1) IT1309588B1 (de)
PT (1) PT1034780E (de)
SK (1) SK284668B6 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL368683A1 (en) * 2001-11-23 2005-04-04 Coloplast A/S A wound dressing
US7887842B2 (en) * 2003-02-07 2011-02-15 Teikoku Pharma Usa, Inc. Methods of administering a dermatological agent to a subject
KR20060059854A (ko) * 2003-08-11 2006-06-02 마이코루 프로다쿠쓰 가부시키가이샤 발열체
DE502005002524D1 (en) 2004-09-01 2008-02-21 Labtec Gmbh Atrium patch
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
RU2342148C2 (ru) * 2005-09-26 2008-12-27 Гликосайенс Лабораториз, Инк. Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および/または運動機能障害の治療薬
WO2008068854A1 (ja) 2006-12-05 2008-06-12 Glycoscience Laboratories, Inc. 変形性関節症の治療剤
FR2918892B1 (fr) * 2007-07-16 2010-02-12 Fabre Pierre Dermo Cosmetique Composition dermatologique anti-inflammatoire comprenant des corticoides et des fragments de hyaluronate, et ses utilisations
US20090307669A1 (en) * 2008-06-06 2009-12-10 Garst Jr Gerald Blaine Memory management for closures
FR2939317B1 (fr) * 2008-12-08 2010-12-24 Oreal Systeme de delivrance trans(epi)dermique comprenant une dispersion vesiculaire, procede de traitement cosmetique et utilisation cosmetique
CN108273115B (zh) * 2018-04-16 2020-06-16 山东威高药业股份有限公司 羟乙基淀粉在制作创面敷料中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
DE3862405D1 (de) 1987-03-09 1991-05-23 Alza Corp Zusammensetzung zur vorbeugung einer kontaktallergie durch gleichzeitiges verabreichen eines kortikosteroids mit einem sensiblisierenden arzneistoff.
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
US5173302A (en) 1990-09-28 1992-12-22 Medtronic, Inc. Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
DE69332378T2 (de) * 1992-07-23 2003-07-10 Hisamitsu Pharmaceutical Co., Inc. Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
ATE205240T1 (de) * 1995-07-04 2001-09-15 Kowa Co Hydrophiles klebemittel
JP4275768B2 (ja) 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
CZ295714B6 (cs) 2005-10-12
ITMI990449A1 (it) 2000-09-05
SK402000A3 (en) 2000-09-12
US6379695B1 (en) 2002-04-30
CA2288482A1 (en) 2000-09-05
CZ200098A3 (cs) 2000-10-11
ES2222860T3 (es) 2005-02-16
HU0000045D0 (en) 2000-03-28
CA2288482C (en) 2008-12-30
PT1034780E (pt) 2004-10-29
ATE269697T1 (de) 2004-07-15
EP1034780A2 (de) 2000-09-13
IT1309588B1 (it) 2002-01-24
HUP0000045A2 (hu) 2001-01-29
EP1034780B1 (de) 2004-06-23
HU225599B1 (en) 2007-05-02
DK1034780T3 (da) 2004-10-25
DE60011686T2 (de) 2005-06-30
SK284668B6 (sk) 2005-08-04
EP1034780A3 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
US6284941B1 (en) Bandage having a scar treatment pad for scar management and scar repair
DK0762860T3 (da) Hudpladeprodukt
DE60011686D1 (de) Mit Betamethasone und Hyaluronsaüre behandeltes dünnes adhäsives Pflaster für die Behandlung von Psoriasis, Dermatitis, und Dermatosis
ES2118004T3 (es) Articulos medicos.
ATE150324T1 (de) Verband mit fenster zum halten eines venenkatheters
ATE221358T1 (de) Verbandssystem
DE69311101D1 (de) Verfahren sowie anordnung zum herstellen von wundverbänden sowie mit diesem verfahren hergestellter wundverband
US20080039760A1 (en) Removable gauze bandage with perforated adhesive strips to adjust bandage
RU94044443A (ru) Средство лейкопластырной повязки, повязки на раны, хирургической простыни или шовного материала. гибкий лист эластомерного материала, резиновая лента для использования в полости рта, шовный материал, зубная щетка, нить для чистки межзубных промежутков
HU225104B1 (en) Method for producing transdermal patches (tts)
DE69707282D1 (de) Wundverband mit hauptteil und griffteil
DE60304477D1 (de) Verbessertes transdermales abgabesystem für die verabreichung von rotigotin
PT92651A (pt) Processo para a preparacao de um sistema terapeutico transdermico compreendendo fisostigmina como ingrediente activo
DE69609595D1 (de) Wundverband mit einem dreidimensionalen teil und verfahren zu seiner herstellung
ATE267008T1 (de) Transdermales oder topisches pflastersystem mit polyacrylatmatrix mit verbesserten physikalischen eigenschaften
SE0403213D0 (sv) Självhäftande förband
DE60204614D1 (de) Narbenbildung fördernder hydrokolloidaler Wundverband, welcher Hyaluronsäure und Chondroitinsulfat enthält
KR20230121116A (ko) 개선된 플라스터
JP3227503B2 (ja) 褥瘡用貼付剤の製法および該製法により作製される褥瘡用貼付剤
GB2301841A (en) Medical articles
ATE400371T1 (de) Moleküle gewisser aktivität empfangender träger und verfahren zur sicherstellung anwesenheit solcher moleküle auf solcher träger
ES1023597U (es) Vendaje terapeutico perfeccionado.
DE69912778D1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition